AbbVie (ABBV)
(Delayed Data from NYSE)
$163.79 USD
+2.98 (1.85%)
Updated May 3, 2024 04:00 PM ET
After-Market: $163.01 -0.78 (-0.48%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 23% (194 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.89 | 2.10 | 9.99 |
Current Quarter Estimate | 3.03 | 37.64 | 57.00 |
Year Ago Quarter Estimate | 2.91 | 11.39 | 52.54 |
Next Quarter Estimate | 2.89 | 34.85 | 61.00 |
Next Year Estimate | 12.07 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 1.35 | 4.80 | 15.67 |
Next Year | 7.19 | 13.90 | 9.31 |
Last 5 Years | 8.20 | 3.00 | 8.10 |
Next 5 Years | 7.00 | 12.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.67 | 15.53 |
Price/Book (MRQ) | 27.84 | 5.62 |
Price/Cash Flow (MRFY) | 10.17 | 9.92 |
Dividend Yield | 3.86% | 2.68% |
Net Profit Margin (TTM) | 11.02% | 12.16% |
Return on Equity (TTM) | 165.18% | 31.29% |
Debt to Equity (MRQ) | NA | 36.14 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.